Diethylcarbamazine (DEC) tablet bulk supplier for pharma manufacturers

Diethylcarbamazine (Dec) Tablet 100 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg

Reference Brands: Generic formulations available in various generic brands

Diethylcarbamazine (DEC) inhibits microfilariae and adult filarial worms, disrupting their metabolism and immune evasion. It effectively treats filariasis and tropical parasitic infections, reducing symptoms, preventing disease transmission, and supporting overall health. Benefits include parasite elimination, symptom relief, and improved quality of life in affected regions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Diethylcarbamazine (DEC) tablets, marketed as Eletcroos and generics, are approved in the US by the FDA and in the EU via EMA for treating lymphatic filariasis and tropical parasitic infections. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, clinical trial and quality data review facilitate approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and global availability, aiding in parasite control and disease prevention worldwide.

Diethylcarbamazine (Dec) Tablet — third party manufacturing & bulk supply

Diethylcarbamazine (Dec) Tablet 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Diethylcarbamazine (Dec) Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Diethylcarbamazine (Dec) Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Diethylcarbamazine (Dec) Tablet →

Back to Listing

Frequently Asked Questions

Diethylcarbamazine is used for treating parasitic infections caused by filarial worms, mainly lymphatic filariasis, loa loa infection, and tropical pulmonary eosinophilia. It helps reduce parasite load in the blood and improves symptoms related to these infections.

Diethylcarbamazine is made from the active pharmaceutical ingredient diethylcarbamazine citrate, a synthetic anti-filarial compound.

The commonly known trade name is Banocide.

Several pharmaceutical companies manufacture Diethylcarbamazine, including GSK (originally for Banocide) and multiple Indian manufacturers producing generic versions.

The generic name is diethylcarbamazine citrate.

Brand name is Banocide.

Diethylcarbamazine is manufactured in several countries, with India being one of the primary producers due to high global demand for filariasis control programs.